Caprioli, F., Fantini, M.C., Marando, F., Scaduto, D. and Ravasio, R. 2024. Cost per Number Needed to Treat (NNT) for upadacitinib in the treatment of bio-exposed patients with moderately-severely active ulcerative rectocolitis. Global and Regional Health Technology Assessment. 11, 1 (Mar. 2024), 55–67. DOI:https://doi.org/10.33393/grhta.2024.2658.